|
|
New No.3, Appaiar Lane, Second Floor,
Royapuram, Chennai - 600 013, Tamilnadu, India
Email - enquiry@multilab.biz, Tele
Fax - +9144 52173177, Mobile - +91 94441 62346
|
|
|
FAQ
> Glossary of Terms > T Series > Treatment
Investigationl New Drug
|
| |
Pharmaceutical & Cleanroom Glossary of Terms
A Series , B
Series , C Series , D
Series , E Series , F
Series , G Series , H
Series , I Series , K
Series , L Series , M
Series , N Series , O
Series , P Series , Q
Series , R Series , S
Series , T Series , U Series
, V Series , W
Series , X
Series , Y Series , Z
Series
Learn About Deadly
Cancer Mesothelioma due to Asbestos Exposure, it can affect
any one in the world
Tangential
Flow Filtration, Taxonomy,
Tay-Sachs Disease,
Team Biologics,
T-Cell(T-Lymphocyte),
Temperature, Terminal
Sterilization, Terminally
Ill, Test Procedure,
Theoretical Yield,
Thermophile, Thermophilic(of
a microorganisms), Thrombin(Blood
Coagulation Factor II), Thrombosis,
Throughput Volume,
Time Stamp, Tincture
of Iodine, Tissue
Culture, Titer,
Titration, TNT(Tumor
Necrosis Therapy), Toe
of Weld, Tolerance,
Ton of Refrigeration,
Topical, Topical
Product, Total
Bacteria Count, Total
Heat(TH), Total
Ionized Salts, Total
Organic Carbon(TOC), Total
Solids, Toxic, Toxicology,
Toxin, Toxoid,
TPA(Tissue
Plasminogen Activator), Trace
Analysis, Traceability,
Tracer, Transcription,
Transduction, Transfection,
Transfer Panel,
Transfer RNA(tRNA),
Transfer Systems,
Transformation,
Transgenics, Translation,
Treatment Investigational New Drug, Trihalomethanes,
Tube Size, Tumor,
Tumor Pathogenesis,
Tumor Suppressor
Genes, Turbidity,
Turnover, Turnover
Package(TOP), Two
Bed Deionizer, Tyrosine(Tyr)
, Total
Dissolved Solids (TDS), Telomere
Learn About Deadly
Cancer Mesothelioma due to Asbestos Exposure, it can affect
any one in the world
Treatment Investigational New Drug
An Investigational New Drug that makes a promising new drug available
to desperately ill patients as early in the drug development process
as available. FDA permits the drug to be used if there is preliminary
evidence of efficacy and it treats a serious or life-threatening
disease, or if there is not comparable therapy available.
|
|
| |
|
|
|